The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kakkar Rahul since 2020.
The trader's CIK number is 1817416.
At the time of the last reporting, Kakkar Rahul was the Chief Executive Officer of Pandion Therapeutics, Inc.. (stock ticker symbol PAND).
Also see all insider trading activities at Pandion Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | PAND | 14,000 | $252,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-21 | PAND | Buy | 14,000 | 18.00 | 252,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kakkar Rahul (Chief Executive Officer of Pandion Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.